In heart failure, it has been demonstrated that soluble ACE2 levels are increased, but there is a paucity of data on the effects of ACE inhibitors on the expression of membrane‐bound cardiac ACE2 in heart failure.19 The gene discussed is ACE2; the disease is heart failure.